Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVINOSTAT vs GLASDEGIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIVINOSTAT vs GLASDEGIB: Safety Overview

Metric GIVINOSTAT GLASDEGIB
Total FAERS Reports 265 521
Deaths Reported 5 196
Death Rate 1.9% 37.6%
Hospitalizations 17 275
Average Patient Age 15.1 yrs 67.4 yrs
% Female Patients 0.4% 38.6%
FDA Approval Date Mar 21, 2024 Nov 21, 2018
Manufacturer Italfarmaco SPA Pfizer Laboratories Div Pfizer Inc
Route ORAL ORAL
Marketing Status Prescription Prescription